Gubra
414.8
DKK
-0.77 %
Less than 1K followers
GUBRA
NASDAQ Copenhagen
Biotechnology & Pharmaceuticals
Health Care
Overview
Ownership
Investor consensus
-0.77%
-23.19%
+11.21%
-37.72%
-33.53%
-24.58%
-
-
+277.09%
Gubra is a pharmaceutical company. The company's operations are focused on the early stages of drug development. They mainly conduct research and development in the field of metabolic and fibrotic diseases. The company's product portfolio includes several brands and pharmaceuticals, and operations are conducted on a global level, with the largest presence in North America and the Nordics. The head office is located in Hørsholm, Denmark.
Read moreMarket cap
6.78B DKK
Turnover
11.2M DKK
Revenue
265.74M
EBIT %
-18.82 %
P/E
-
Dividend yield-%
14.75 %
Coverage
Latest research
Latest analysis report
Released: 17.03.2025
Financial calendar
21.8
2025
Interim report Q2'25
27.2
2026
Annual report '25
All
Research
Webcasts
Press releases
ShowingAll content types
Reporting of transactions made by persons discharging managerial responsibilities and persons closely associated with them in Gubra A/S' shares
Reporting of transactions made by persons discharging managerial responsibilities and persons closely associated with them in Gubra A/S' shares
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools